Skip to main content Skip to navigation

News


Select tags to filter on

Understanding how to stop ice growth with amino acids

The GibsonGroup, working with the Sosso Group in chemistry have demonstrated that simple amino acids can slow the recrystallisation of ice. Ice recrystallisation inhibition (IRI) is normally associated with ice binding proteins, but the team show that amino acids can also achieve this. Using a combination of experiments and modelling the importance of the structure of the amino acid is explored, and the relative role of ice binding investigated.

Read the paper here.

Tue 12 Apr 2022, 10:53 | Tags: GRPNews Health GRP

Multiple sclerosis and the Epstein Barr virus

Multiple sclerosis mystery solved: Glandular fever virus is the cause.

Fri 11 Mar 2022, 09:29 | Tags: GRPNews Health GRP

AMR programme: call for Research Fellow Mentors

Monash Warwick Alliance antimicrobial resistance (AMR) training programme in Emerging Superbug Threats – Call for Research Fellow Mentors

Academic colleagues are invited to apply to become a mentor for a philanthropically funded research fellow associated with this programme, which aims to deliver interdisciplinary AMR research training across the Warwick and Monash campuses to recent PhD graduates with relevant expertise. Further information about the goals and structure of the programme, and details of how to apply can be found here https://warwick.ac.uk/global/partnerships/mwa/current/amr/. The deadline for submitting applications is 28 Feb 2022.

Fri 11 Feb 2022, 09:10 | Tags: GRPNews Health GRP

Lighting Up Tumour Treatments

The Perrier Lab have just published a new study in Angewandte Chemie which shows how polymeric nanotubes can be designed to switch their fluorescence on as they deliver a commercial anticancer drug (doxorubicin), thereby permitting the in-situ visualization of drug release. By this method, we can both treat a cancer tumour and show where the tumour is located. These theranostic systems (from therapeutic and diagnostic) form a new approach to drug delivery.

Read the paper here.

Thu 20 Jan 2022, 12:48 | Tags: GPP GRPNews

6 of the biggest good news cancer stories of 2021

2021 may not have been the year anyone expected, with COVID-19 still making its presence known in our lives and around the world.

But a lot of progress has still been made. From promising new cancer drugs to trialling a cancer blood test, here are some of the top good news stories from the year.

Wed 12 Jan 2022, 09:08 | Tags: Cancer Research Centre GRPNews

Over 600 people in England set to benefit from innovative lung cancer treatment

More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence (NICE).

The drug will now be available to people with early-stage non small cell lung cancer (NSCLC) who have had surgery to remove their tumour that has errors in a gene called EGFR.

Wed 15 Dec 2021, 09:01 | Tags: Cancer Research Centre GRPNews

AHSN Funding Newsletter November 2021

Welcome to November's AHSN Funding Newsletter. This bulletin alerts you to funding opportunities, international opportunities, events and other relevant AHSN news. For each opportunity we have provided a brief summary and a link to full details.

Thu 25 Nov 2021, 15:25 | Tags: funding GRPNews Health GRP

How insulin has changed diabetes care, 100 years on

Dr Thomas Barber was interviewed by Medical News Today on current insulin research and potential future developments. Listen to the interview here.

Wed 17 Nov 2021, 13:18 | Tags: GRPNews Health GRP

Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers

An immunotherapy combination could be better than standard ‘Extreme’ chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or both, a major phase III trial suggests.

Tue 12 Oct 2021, 13:19 | Tags: GPP GRPNews Health GRP

Cholesterol drug appraised by WMS researchers to be made available on NHS

A new drug to lower cholesterol which was appraised by Warwick Evidence will be made available to hundreds of thousands of NHS patients

Mon 20 Sep 2021, 12:32 | Tags: GRPNews Health GRP

Patient Community Hub

A new Patient Public Community Hub has been launched within Academic Primary Care, with content developed with NIHR Research Champions (public volunteers who raise awareness about research ) from the West Midlands. The hub is aimed at helping to create an environment that makes local health research results more accessible to the public and provides opportunities for local involvement and engagement with health research. It's being developed as part of a qualitative research project by Eleanor Hoverd, Research Nurse and NIHR Pre-doctoral Clinical Academic Fellow at UAPC, supervised by Professor Sophie Staniszewska and Professor Jeremy Dale.

Thu 26 Aug 2021, 09:38 | Tags: GRPNews Health GRP

Making a difference to the health and wellbeing of our region

We've just launched a new network, in partnership with University Hospitals Coventry and Warwickshire (UHCW) and Bruntwood SciTech, called the West Midlands Health and Wellbeing Innovation Network. The Network will find and develop the next big innovations in healthcare transformation.

Using the expertise and resources of the University and hospital, businesses in the healthcare, technology and wellbeing sectors can benefit and grow, and ultimately help us to take on new and existing healthcare challenges. The Network has also received £100,000 funding from the West Midlands Combined Authority's Innovation Programme to create and develop responses to health challenges that will impact our region. Read on below to find out more about the Network.

Thu 29 Jul 2021, 08:31 | Tags: GRPNews Health GRP

High respiratory efforts in COVID-19 patients could result in self-inflicted lung injury

The impact of high breathing efforts on the lungs of patients suffering with acute respiratory failure due to COVID-19 has been investigated by researchers at the University of Warwick, who assessed the likelihood of resulting lung injury.

Thu 22 Jul 2021, 09:15 | Tags: GRPNews Health GRP

Centre for Mental Health & Wellbeing awarded £3million

The Centre for Mental Health & Wellbeing has been awarded £3,608,627 in NIHR funding to undertake an asset-based approach to improve access to mental health care in slums, entitled 'The TRANSFORM Project.'

Slum populations in low and middle-income countries (LMICs) have high rates of serious and enduring mental disorders (SMDs – psychotic disorders and severe mood disorders, often with co-occurring substance abuse) and very poor access to mental health care. Sufferers and their families often choose traditional and faith-based practices since these are more accessible, considered affordable, and are in tune with their cultural beliefs and traditions. Faith-based and traditional healing can play an important part in delivering care in LMICs, especially for common mental disorders like anxiety and depression, both in Sub-Saharan Africa and the Indian subcontinent but those with SMDs require additional biomedical treatment and follow-up.

The TRANSFORM project aims to improve access to care and outcomes of SMDs in slums, by developing an innovative collaborative care model involving traditional/faith healers, mental health professionals, primary care practitioners and community health workers (CHWs). This multidisciplinary research programme is being conducted across two slum communities in two ODA-eligible countries.

We are conducting in-depth studies to understand local communities' awareness and understanding of SMDs and sit with traditional and faith healers to understand who seeks care, how care is given and how healers identify and could refer those with treatable SMDs to medical care. We will develop an understanding of the explanatory models of illness and care in relation to SMDs from the perspectives of community members, healers and health professionals.

Based on these findings, we will develop two training packages, one for healers and one for CHWs, focused on identification, referral to local psychiatric services and ongoing support for patients (18+) with SMDs. We will evaluate the effectiveness of the training programmes in increasing referrals to and the provision of community mental health care of cases of SMDs and conduct a cost-effectiveness analysis of the intervention and its outcomes.

The proposal was developed in detailed discussion with local research teams, slum community leaders, CHWs and local traditional/faith healers, who will be ongoing partners of the project. Besides disseminating findings through the usual channels of scientific publications and policy papers, we will develop street theatre and documentary films on our findings to increase the impact of our research and to further engage slum communities, raise awareness, reduce stigma and provide information on plural health care for SMDs.

Fri 09 Jul 2021, 09:35 | Tags: GRPNews Health GRP

Major Funding Secured for ground-breaking Terabotics project at UHCW NHS Trust

Cancer services at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust are set for a ground-breaking advancement, with major funding secured to develop technology that can detect tumours and guide robots to remove them.

The Terabotics project, which is being led by Professor Emma Pickwell-MacPherson at the University of Warwick, will use probes that use terahertz (THz) radiation, or T-rays, to scan for tumours under the skin.

Thu 08 Jul 2021, 13:00 | Tags: GRPNews Health GRP

Latest news Newer news Older news